+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Eluting Stent Market Size, Share & Trends Analysis Report By Coating Type (Polymer-based Coatings (Non-biodegradable, Biodegradable)), Polymer-free Coatings, By Application, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5893161
Description Jump to:
The global drug eluting stent market size is expected to reach USD 13.65 billion by 2030, advancing at a CAGR of 8.4% during the forecast period. An aging population and the increasing prevalence of risk factors such as cardiovascular diseases (CVDs), complex lesions, diabetes, obesity, and others are expected to drive the demand for drug eluting stents over the forecast period. Additionally, ongoing technological advancements in stent design, including improvements in coatings and drug delivery mechanisms, are enhancing the safety and efficacy of these devices, making them more appealing to patients and healthcare professionals.

The increasing prevalence of cardiovascular diseases globally has fueled market demand. According to the World Health Federation report in 2022, over half a billion people globally continue to be affected by cardiovascular diseases, with CVD contributing to approximately 20.5 million deaths in 2021, accounting for nearly a third of all deaths globally. Conditions like coronary artery disease and peripheral artery disease are becoming increasingly common, leading to a surge in demand for effective treatment options such as DES. These stents, equipped with drug-coated surfaces, offer patients a minimally invasive solution, effectively preventing restenosis and leading to improved patient outcomes.

The market for drug eluting stents was significantly impacted by the COVID-19 pandemic, with disruptions in the supply chain of medical devices. Since the focus of all major manufacturers was to fight the COVID-19 battle, the revenues of other segments were highly impacted. All notable competitors in the market for coronary stents announced a decline in revenue for their interventional cardiology portfolios, which include coronary stent devices in 2020, owing mostly to the impact of the COVID-19 pandemic.

Drug Eluting Stent Market Report Highlights

  • Based on coating, the polymer-based coating segment held the dominant revenue share of 82.9% in 2022. This share can be attributed to its extensive usage in stent development, proven efficacy in drug delivery, and versatility in accommodating various therapeutic agents, making it a preferred choice for manufacturers and healthcare professionals alike. Additionally, continuous advancements in polymer-based coating technology have further solidified its leading position in the market
  • Based on application, the market for drug eluting stents has been categorized into coronary artery disease and peripheral artery disease, with the former accounting for 85.9% of the revenue share in 2022. The growth can be attributed to the high prevalence of coronary artery disease globally, leading to a substantial demand for effective treatment options such as drug eluting stents
  • The North American region held the largest revenue share of 43.08% in 2022 and is expected to dominate the market through the forecast period. North America has a well-developed and advanced healthcare infrastructure, including hospitals. Additionally, the increasing prevalence of cardiovascular diseases in the region has driven the demand for effective treatment options such as drug eluting stents


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Increasing Prevalence of Cardiovascular Diseases
3.4.2. Technological Advancements in Stent Design
3.4.3. Growing Geriatric Population
3.5. Market Restraint Analysis
3.5.1. High Cost of Drug Eluting Stents
3.6. Penetration And Growth Prospect Mapping 2022
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.7.2. Porter’s Five Forces Analysis
3.8. COVID-19 Impact Analysis
Chapter 4. Drug Eluting Stent Market: Coating Type Segment Analysis
4.1. Drug Eluting Stent: Market Share Analysis, 2022 & 2030
4.2. Polymer-Based Coating
4.2.1. Polymer-Based Coating Market, 2018 - 2030 (USD Billion)
4.2.1.1. Non-Biodegradable Polymers
4.2.1.2. Biodegradable Polymers
4.3. Polymer-free Coating
4.3.1. Polymer-Free Coating Market, 2018 - 2030 (USD Billion)
4.3.1.1. Micro Porous Surface
4.3.1.2. Micro Structured Surface
4.3.1.3. Slotted Tubular Surface
4.3.1.4. Nanoporous Surface
Chapter 5. Drug Eluting Stent Market: Application Segment Analysis
5.1. Drug Eluting Stent: Market Share Analysis, 2022 & 2030
5.2. Coronary Artery Disease
5.2.1. Coronary Artery Disease Market, 2018 - 2030 (USD Billion)
5.3. Peripheral Artery Disease
5.3.1. Peripheral Artery Disease Market, 2018 - 2030 (USD Billion)
Chapter 6. Drug Eluting Stent Market: Regional Analysis
6.1. Drug Eluting Stent Market Share, By Region, 2022 & 2030
6.2. North America
6.2.1. North Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. Competitive Scenario
6.2.2.3. Regulatory Framework
6.2.2.4. U.S. Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Competitive Scenario
6.2.3.3. Regulatory Framework
6.2.3.4. Canada Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.3. Europe
6.3.1. Europe Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. UK Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Germany Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. France Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Competitive Scenario
6.3.5.3. Regulatory Framework
6.3.5.4. Italy Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Competitive Scenario
6.3.6.3. Regulatory Framework
6.3.6.4. Spain Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Competitive Scenario
6.3.7.3. Regulatory Framework
6.3.7.4. Denmark Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Competitive Scenario
6.3.8.3. Regulatory Framework
6.3.8.4. Sweden Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Competitive Scenario
6.3.9.3. Regulatory Framework
6.3.9.4. Norway Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.4. Asia Pacific
6.4.1. Asia Pacific Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. Japan Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. China Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. India Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.4.5. Australia
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Australia Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.4.6. Thailand
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Thailand Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.4.7. South Korea
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. South Korea Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.5. Latin America
6.5.1. Latin America Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Brazil Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.5.3. Mexico
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Mexico Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Argentina Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.6. MEA
6.6.1. MEA Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. South Africa Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Saudi Arabia Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. UAE Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Kuwait Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Market Share Analysis, 2022
7.4. Company Profiles/Listing
7.4.1. Abbott Laboratories
7.4.1.1. Overview
7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Boston Scientific Corporation
7.4.2.1. Overview
7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Terumo Corporation
7.4.3.1. Overview
7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Medtronic
7.4.4.1. Overview
7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Biosensors International
7.4.5.1. Overview
7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Cook Medical
7.4.6.1. Overview
7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. B. Braun
7.4.7.1. Overview
7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Biotronik
7.4.8.1. Overview
7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Lepu Medical Technology
7.4.9.1. Overview
7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 List of Secondary Sources
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Drug eluting stent market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 13 Porter’s Five Forces analysis
Fig. 14 Market penetration & growth prospect mapping, 2022
Fig. 15 Global drug eluting stent market: Coating type movement analysis
Fig. 16 Global drug eluting stent market, for polymer-based coating, 2018 - 2030 (USD Billion)
Fig. 17 Global drug eluting stent market, for polymer-free coating, 2018 - 2030 (USD Billion)
Fig. 18 Global drug eluting stent market: Application movement analysis
Fig. 19 Global drug eluting stent market, for coronary artery disease, 2018 - 2030 (USD Billion)
Fig. 20 Global drug eluting stent market, for peripheral artery disease, 2018 - 2030 (USD Billion)
Fig. 21 Regional marketplace: Key takeaways
Fig. 22 Regional outlook, 2022 & 2030
Fig. 23 Global drug eluting stent market: Regional movement analysis
Fig. 24 North America drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 25 U.S. drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 26 Canada drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 27 Europe drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 28 Germany drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 29 UK drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 30 France drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 31 Italy drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 32 Spain drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 33 Denmark drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 34 Sweden drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 35 Norway drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 36 Asia Pacific drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 37 Japan drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 38 China drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 39 India drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 40 Australia drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 41 South Korea drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 42 Thailand drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 43 Latin America drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 44 Brazil drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 45 Mexico drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 46 Argentina drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 47 Middle East and Africa drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 48 South Africa drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 49 Saudi Arabia drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 50 UAE drug eluting stent market, 2018 - 2030 (USD Billion)
Fig. 51 Kuwait drug eluting stent market, 2018 - 2030 (USD Billion)

Companies Mentioned

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic
  • Biosensors International
  • Cook Medical
  • B. Braun
  • Biotronik
  • Lepu Medical Technology

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 7.2 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.65 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Global Drug Eluting Stent Market by Drug Coating (Polymer Free Coatings, Polymer-Based Coatings), Application (Coronary Artery Disease, Peripheral Artery Disease) - Forecast 2024-2030 - Product Image

Global Drug Eluting Stent Market by Drug Coating (Polymer Free Coatings, Polymer-Based Coatings), Application (Coronary Artery Disease, Peripheral Artery Disease) - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents (BMS), Drug Eluting Stents (DES), Bioresorbable Vascular Scaffold), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents (BMS), Drug Eluting Stents (DES), Bioresorbable Vascular Scaffold), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 110 Pages
  • Global
From
Global Drug Eluting Stent Market Size, Share & Industry Trends Analysis Report By Application (Coronary Artery Disease, and Peripheral Artery Disease), By Coating Type, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Drug Eluting Stent Market Size, Share & Industry Trends Analysis Report By Application (Coronary Artery Disease, and Peripheral Artery Disease), By Coating Type, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 350 Pages
  • Global
From
Peripheral Vascular Stents Market Size, Share & Trends Analysis Report By Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents), By Mode of Delivery, By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Peripheral Vascular Stents Market Size, Share & Trends Analysis Report By Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents), By Mode of Delivery, By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 100 Pages
  • Global
From
Global Drug Eluting Stent Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Drug Eluting Stent Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 177 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.